We evaluate metabolic health — not just BMI.
GLP-1 eligibility is based on clinical criteria — but those criteria are broader than most people realize. Dr. Kresch evaluates each patient individually based on their complete metabolic picture, not just a single number.
Clinically eligible for GLP-1 therapy under standard FDA-approved criteria. This is the primary indication for Zepbound (tirzepatide) and Wegovy (semaglutide). Insurance typically covers medication at this threshold when appropriate documentation is submitted.
Patients with a BMI between 27 and 30 who have at least one weight-related comorbidity are clinically eligible under FDA-approved labeling. Qualifying conditions include hypertension, type 2 diabetes, sleep apnea, PCOS, or dyslipidemia/high cholesterol. Many insurance plans cover GLP-1 medications at this threshold.
Patients in this range may qualify — lab work helps determine. Elevated fasting insulin, insulin resistance (HOMA-IR), elevated ApoB, or a strong family history of metabolic disease may support clinical eligibility. Dr. Kresch evaluates these patients on a case-by-case basis and will give you a candid assessment after reviewing your labs and history.
If your insurance denied coverage for GLP-1 therapy, that is not the end of the road. As a cash-pay practice, Restora Health has no insurance gatekeeping. Dr. Kresch will evaluate your clinical picture and, if you are a good candidate, she will prescribe appropriately. She can also assist with prior authorization documentation and appeals for patients seeking insurance coverage for medication costs.
Patients with these conditions are frequently candidates for GLP-1 therapy. They also benefit from the comprehensive metabolic monitoring that is central to Restora Health's program.
Important: This is a general guideline. Final eligibility is determined by Dr. Kresch after reviewing your full history and labs. The only way to know for certain is to book a consultation — and if you're not a good candidate, Dr. Kresch will tell you plainly.
Dr. Kresch reviews every patient's labs, history, and risk factors personally. She will tell you candidly whether GLP-1 therapy is right for you — and why. $150 · 30 min · FL & NY telehealth.
Book a ConsultationNo obligation to join · HSA/FSA eligible · Cancel anytime after